SCHEDULE OF WARRANTS ACTIVITY (Details) - $ / shares |
9 Months Ended | 12 Months Ended |
---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
|
Warrants | ||
Warrants outstanding, beginning balance | 161,500 | 199,000 |
Weighted average exercise price, beginning balance | $ 1.09 | $ 1.07 |
Warrants, granted | ||
Weighted average exercise price, granted | ||
Warrants, canceled | (11,500) | (12,500) |
Weighted average exercise price, canceled | $ 1.00 | $ 1.00 |
Warrants, exercised | (25,000) | |
Weighted average exercise price, exercised | $ 1.00 | |
Warrants outstanding, ending balance | 150,000 | 161,500 |
Weighted average exercise price, ending balance | $ 1.10 | $ 1.09 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price cancelled. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price exercised. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price granted. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|